Terms: = Sarcomas AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Diagnosis
6 results:
1. Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.
Cyrta J; Gauthier A; Karanian M; Vieira AF; Cardoen L; Jehanno N; Bouvet M; Bouvier C; Komuta M; Le Loarer F; Orbach D; Rome A; Minard-Colin V; Brichard B; Pluchart C; Thebaud E; Renard M; Pannier S; Brisse H; Petit P; Benoist C; Schleiermacher G; Geoerger B; Vincent-Salomon A; Fréneaux P; Pierron G
Am J Surg Pathol; 2021 Jun; 45(6):854-867. PubMed ID: 33949344
[TBL] [Abstract] [Full Text] [Related]
2. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
[TBL] [Abstract] [Full Text] [Related]
3. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
[TBL] [Abstract] [Full Text] [Related]
4. Expression of FGFR3 and fgfr4 and clinical risk factors associated with progression-free survival in synovial sarcoma.
Charbonneau B; Vogel RI; Manivel JC; Rizzardi A; Schmechel SC; Ognjanovic S; Subramanian S; Largaespada D; Weigel B
Hum Pathol; 2013 Sep; 44(9):1918-26. PubMed ID: 23664540
[TBL] [Abstract] [Full Text] [Related]
5. The involvement of fibroblast growth factor receptor signaling pathways in dermatofibroma and dermatofibrosarcoma protuberans.
Ishigami T; Hida Y; Matsudate Y; Murao K; Kubo Y
J Med Invest; 2013; 60(1-2):106-13. PubMed ID: 23614918
[TBL] [Abstract] [Full Text] [Related]
6. Bone mineral density deficits in pediatric patients treated for sarcoma.
Kaste SC; Ahn H; Liu T; Liu W; Krasin MJ; Hudson MM; Spunt SL
Pediatr Blood Cancer; 2008 May; 50(5):1032-8. PubMed ID: 17570705
[TBL] [Abstract] [Full Text] [Related]